D. Crutchley

发表

PROSTAGLANDIN INACTIVATION IN GUINEA‐PIG LUNG AND ITS INHIBITION

P. Piper, D. Crutchley, 1974, British journal of pharmacology.

459. The chemistry of bacteria. Part VIII. The synthesis of violacein and related compounds

D. Crutchley, J. Ballantine, R. Beer, 1960 .

Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery.

U. Ryan, J. Ryan, D. Crutchley, 1980, The Journal of clinical investigation.

The stable prostacyclin analog, iloprost, and prostaglandin E1 inhibit monocyte procoagulant activity in vitro.

D. Crutchley, M. Hirsh, DJ Crutchley, 1991, Blood.

Copper-induced tissue factor expression in human monocytic THP-1 cells and its inhibition by antioxidants.

D. Crutchley, B. G. Que, B. Que, 1995, Circulation.

Levels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitor.

D. Crutchley, M. Canossa-Terris, G. McPhee, 1989, Arteriosclerosis.

Effects of inhibitors of arachidonic acid metabolism on thromboplastin activity in human monocytes.

D. Crutchley, 1984, Biochemical and biophysical research communications.

Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.

D. Crutchley, L. B. Conanan, J. Maynard, 1982, The Journal of pharmacology and experimental therapeutics.

Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells. Studies with lower homologs and calcium antagonists.

G. Fisher, U. Ryan, J. Ryan, 1983, Biochimica et biophysica acta.

The pulmonary endothelial surface.

U. Ryan, J. Ryan, D. Crutchley, 1985, Federation proceedings.

Effects of prostacyclin analogues on human endothelial cell tissue factor expression.

Assaf Toledo, D. Solomon, D. Crutchley, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.

D. Solomon, D. Crutchley, L. B. Conanan, 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

K+ channel blockers inhibit tissue factor expression by human monocytic cells.

D. Crutchley, B. Que, L. B. Conanan, 1995, Circulation research.

Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.

D. Crutchley, L. B. Conanan, 1986, The Journal of biological chemistry.

Induction of plasminogen activator by 12-O-tetradecanoylphorbol-13-acetate and calcium ionophore. Suppression by inhibitors of fatty acid lipoxygenase.

D. Crutchley, J. Maynard, 1983, Biochimica et biophysica acta.

Calcium regulation of tissue plasminogen activator and prostaglandin biosynthesis in HeLa cells.

D. Crutchley, P. Smariga, 1986, Biochimica et biophysica acta.

Studies on the covalent binding of an intermediate(s) in prostaglandin biosynthesis to tissue macromolecules.

A. Wilson, T. Eling, M. Anderson, 1979, Biochimica et biophysica acta.

Hydroxyeicosatetraenoic acids and other unsaturated fatty acids inhibit endotoxin-induced thromboplastin activity in human monocytes.

D. Crutchley, 1985, Biochemical and biophysical research communications.

lnduction of Plasminogen Activator and Prostaglandin Biosynthesis in HeLa Cells by 12-O-Tetradecanoylphorbol-1 3-acetate

D. Crutchley, L. B. Conanan, J. Maynard, 2006 .

Induction of plasminogen activator and prostaglandin biosynthesis in HeLa cells by 12-O-tetradecanoylphorbol-13-acetate.

D. Crutchley, L. B. Conanan, J. Maynard, 1980, Cancer research.

ADPase activity of isolated perfused rat lung.

T. Eling, M. Anderson, D. Crutchley, 1978, Life sciences.

The nature of prostaglandin-like substances released from guinea-pig lung in anaphylaxis.

P. Piper, D. Crutchley, J. Seale, 1977, European journal of pharmacology.

Assay of three hemostatic factors (prostacyclin, plasminogen activator, and thromboplastin) in bovine pulmonary endothelial cells

D. Crutchley, 1986 .

HUMAN FIBROBLASTS PRODUCE INHIBITOR DIRECTED AGAINST PLASMINOGEN ACTIVATOR WHEN TREATED WITH GLUCOCORTICOIDS *

D. Crutchley, L. Conanan, J. Maynard, 1981, Annals of the New York Academy of Sciences.

Hemostatic Potential of the Pulmonary Endothelium

D. Crutchley, 1987 .

Serum-dependent induction of plasminogen activator in human fibroblasts by catecholamines and comparison with the effects of prostaglandin E1.

D. Crutchley, L. B. Conanan, 1983, Biochimica et biophysica acta.

The behaviour of the pulmonary metabolites of prostaglandins in several simple thin-layer chromatography and bioassay systems.

P. Piper, D. Crutchley, 1976, Prostaglandins.

INHIBITION OF THE PULMONARY INACTIVATION OF PROSTAGLANDINS in vivo BY DI‐4‐PHLORETIN PHOSPHATE

P. Piper, D. Crutchley, 1975, British journal of pharmacology.

Endotoxin-induced secretion of an active plasminogen activator inhibitor from bovine pulmonary arterial and aortic endothelial cells.

U. Ryan, D. Crutchley, L. B. Conanan, 1987, Biochemical and biophysical research communications.

Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells.

D. Crutchley, B. Que, L. B. Conanan, 1994, The Journal of pharmacology and experimental therapeutics.

The Journal

W. Mitch, D. Brunswick, W. Dewey, 1859, Archives of internal medicine.

Enhanced thromboxane B2 release from challenged guinea pig lung after oxygen exposure.

T. Eling, D. Crutchley, J. Boyd, 1980, The American review of respiratory disease.

Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.

B. Tainer, T. Eling, M. Anderson, 1978, Prostaglandins.

COMPARATIVE BIOASSAY OF PROSTAGLANDIN E2 AND ITS THREE PULMONARY METABOLITES

P. Piper, D. Crutchley, D.J. CRUTCHLEY, 1975, British journal of pharmacology.

Glucocorticoid modulation of prostacyclin production in cultured bovine pulmonary endothelial cells.

U. Ryan, J. Ryan, D. Crutchley, 1985, The Journal of pharmacology and experimental therapeutics.

Bioassay and thin-layer chromatography of prostaglandins and their pulmonary metabolites [proceedings].

P. Piper, D. Crutchley, K. Crutchley, 1976, British journal of pharmacology.